Methodological quality assessment for traditional Chinese medicine: CONSORT is better

Hepatology

Volumn 53, Issue 6, 2011, Pages 2148-2149

  Zheng, Ming Hua ^a   Fan, Yu Chen ^b   Shi, Ke Qing ^a   Chen, Yong Ping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b Shandong University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE MEDICINE; CONSOLIDATED STANDARD OF REPORTING TRIAL STATEMENT; EVIDENCE BASED MEDICINE; JADAD SCORING; LETTER; MEDICAL RESEARCH; METHODOLOGY; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM;

CHINA; HUMANS; MEDICINE, CHINESE TRADITIONAL; QUALITY ASSURANCE, HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 79957499021     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24126     Document Type: Letter

References (6)

1. Zhang L, Wang G, Hou W, Li P, Dulin A, Bonkovsky HL. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology 2010; 51: 690-698.
2. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
3. Berger VW. Is the Jadad score the proper evaluation of trials? J Rheumatol 2006; 33: 1710-1711.
4. Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D, et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials 1999; 20: 448-452.
5. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285: 1987-1991.
6. Wu TX, Li YP, Bian ZX, Li TQ, Li J, Dagenais S, et al. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM) [in Chinese]. Chin J Evid Based Med 2007; 7: 601-605.